(lp0
S'Trovagene to Present at the Sidoti &amp; Company Spring 2017 Convention PR Newswire  - Mar 21, 2017 SAN DIEGO, March 21, 2017 /PRNewswire/ -- Trovagene, Inc. , a precision medicine biotechnology company, today announced that its Chief Executive Officer, Bill Welch, will present at the Sidoti &amp; Company Spring 2017 Convention on&nbsp;...'
p1
aS'Trovagene Reports Fourth Quarter and Year End 2016 Financial Results PR Newswire  - Mar 15, 2017 SAN DIEGO, March 15, 2017 /PRNewswire/ -- Trovagene, Inc. , a precision medicine biotechnology company today reported financial results for the fourth quarter and year ended December 31, 2016.Trovagene nabs rights to leukemia candidate from Nerviano Medical - Seeking AlphaWhy TrovaGene Inc  Reported Restructuring Plan? - StockNewsUnion'
p2
aS'Trovagene to Announce Fourth Quarter and Year End 2016 Financial Results and ... PR Newswire  - Mar 1, 2017 SAN DIEGO, March 1, 2017 /PRNewswire/ -- Trovagene, Inc. , a developer of circulating tumor DNA  molecular diagnostics, announced today that it will report financial results for the fourth quarter and year ended December 31, 2016&nbsp;...'
p3
aS"Form 8-K Trovagene, Inc. For: Mar 27 StreetInsider.com - Mar 27, 2017 On March 27, 2017, Trovagene, Inc.  issued a press release announcing that its Chief Executive Officer, Bill Welch, will be presenting at this year's MicroCap Conference on April 4, 2017 at 9:00 AM EDT at the Essex House in New York City."
p4
aS'Trovagene Announces Broadening Network of Commercial Distributors PR Newswire  - Jan 12, 2017 SAN DIEGO, Jan. 12, 2017 /PRNewswire/ -- Trovagene, Inc. , a developer of circulating tumor DNA  technologies, today announced that it has signed agreements with seven strategic partners across Europe and the Middle East for&nbsp;...Trovagene inks seven deals for commercialization of liquid biopsy tests ex-US - Seeking Alpha'
p5
aS'Trovagene announces a reorganization to accelerate global distribution of ... PR Newswire  - Dec 13, 2016 SAN DIEGO, Dec. 13, 2016 /PRNewswire/ -- Trovagene, Inc. , a developer of circulating tumor DNA  molecular diagnostics, announced today that it will increase its focus on the global distribution of kits and systems to clinical&nbsp;...Trovagene to Focus More on Liquid Biopsy Testing Market - Yahoo FinanceTrovagene Axes 20 Staffers, Refocuses on Distributing Kits, Systems - Genetic Engineering & Biotechnology News'
p6
aS'Trovagene to Attend the 29th Annual ROTH Conference PR Newswire  - Feb 28, 2017 SAN DIEGO, Feb. 28, 2017 /PRNewswire/ -- Trovagene, Inc. , a developer of circulating tumor DNA  molecular diagnostics, is scheduled to attend the 29th Annual ROTH Conference, March 12-15, 2017, at the Ritz Carlton Laguna&nbsp;...'
p7
aS"Today Analysts Focus on Healthcare Realty Trust Incorporated , TrovaGene ... StockNewsJournal - Mar 23, 2017 TrovaGene, Inc. , maintained return on investment for the last twelve months at -78.88, higher than what Reuters data shows regarding industry's average.TrovaGene, Inc. : How technical signals have emerged? - Post AnalystThe TrovaGene Inc  Cut to Hold at Maxim Group - Petro Global News 24"
p8
aS'Earnings Reaction History: TrovaGene, Inc., 75.0% Follow-Through Indicator, 7 ... Nasdaq - Mar 15, 2017 TrovaGene, Inc.  is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.'
p9
aS"Top Bullish Stock Inside Investors Spotlight: TrovaGene, Inc.'s  stock ... WsNews 4investors - 16 hours ago TrovaGene, Inc.  stock price distance from twenty day simple moving average slumped at -30.93% while its distance from fifty day simple moving average declined -42.48% along with -69.12% below distance from two hundred simple moving averages."
p10
a.